UNSPSC 51422316: Prednylidene

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IF8PQP966U, chemically known as 11beta,17,21-trihydroxy-16-methylenepregna-1,4-diene-3,20-dione but generally known as prednylidene, which bears US NIH Compound Identifier 11740. European Medicines Agency schedules Prednylidene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10021MIG.

UNSPSC 51422316 Prednylidene is a Commodity code that does not align with the recent state and local procurement activity posted under it. The single recent opportunity—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with response due July 26, 2023—solicits naloxone and drug deactivation systems for community health support, not prednylidene (a corticosteroid pharmaceutical). The mismatch suggests either a tagging error in the state or local procurement database or a divergence between the code's nominal scope and current usage patterns. No other recent state and local opportunities appear under this code in the available record.

Given the single misaligned opportunity and absence of additional activity, the code shows little relevant recent procurement volume for business development purposes. The Seminole County solicitation itself presents a standalone health-systems opportunity—naloxone and deactivation equipment for quarterly delivery to a community health facility, with E-Verify compliance and federal compliance riders (Clean Air Act, Federal Water Pollution Control Act) tied to potential FEMA funding—but this activity falls outside the prednylidene pharmaceutical scope the code nominally describes. Practitioners pursuing state and local pharmaceutical or medical-device procurement should verify coding accuracy in source systems before committing resources to this classification.